Considering that the development of liver fibrosis is strongly associated with overweight/obesity, insulin resistance and steatosis [7,47,48], we think that the association between the FTO rs9939609 polymorphism and liver fibrosis might be mediated by the metabolic disorders related to CHC. Here, FTO is linked to obesity disorder.